Skip to content

The risk factors of large intestine polyps associated with rheumatoid arthritis were analyzed retrospectively

The risk factors of large intestine polyps associated with rheumatoid arthritis were analyzed retrospectively - The risk factors of large intestine polyps associated with rheumatoid arthritis were analyzed retrospectively

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084636
Enrollment
Unknown
Registered
2024-05-22
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis with large intestine polyps

Interventions

Observation group (A history of rheumatoid arthritis combination of colon polyps):None
Control group 1 (Patients with rheumatoid arthritis but no large intestine polyps):None
Control group 2 (Patients with large bowel polyps without autoimmune disease):None
Control group 3 (Patients with no autoimmune disease and no large intestine polyps):None

Sponsors

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
39 Years to 82 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of rheumatoid arthritis in Western medicine in 2010; ? It meets the diagnostic criteria of large intestine polyp; ? Improve colonoscopy; ?Age and gender were not limited; ? Complete clinical data required.

Exclusion criteria

Exclusion criteria: ? Overlapping systemic lupus erythematosus, ankylosing spondylitis, primary Sjogren's syndrome and other rheumatic diseases; ? Patients with severe heart, liver and renal insufficiency;?Patients with serious cardiovascular and cerebrovascular diseases, blood system diseases, severe hypertension, severe diabetes and other major diseases; ? Complicated with severe infected persons.

Design outcomes

Primary

MeasureTime frame
Erythrocyte sedimentation rate;IgM rheumatoid factor;IgA rheumatoid factor;IgG rheumatoid factor;Anti-ccp antibody;

Secondary

MeasureTime frame
HLA-B27;C-reactive protein;

Countries

China

Contacts

Public ContactChaonan Li

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine

962640821@qq.com+86 133 8620 5983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026